Patent Assignment
Reel/Frame 065251/0947
Assignment of Assignor's Interest
Recorded: 2023-10-17
Pages: 3
Assignee
MYELOID THERAPEUTICS, INC.
300 TECHNOLOGY SQUARE, SUITE 203, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Engineered Chimeric Fusion Protein Compositions and Methods of Use Thereof
Application:
18/486,563 →
Publication:
US 2024/0139314
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.